Literature DB >> 14657371

Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria.

Chetan Bettegowda1, Long H Dang, Ross Abrams, David L Huso, Larry Dillehay, Ian Cheong, Nishant Agrawal, Scott Borzillary, J Michael McCaffery, E Latice Watson, Kuo-Shyan Lin, Fred Bunz, Kwamena Baidoo, Martin G Pomper, Kenneth W Kinzler, Bert Vogelstein, Shibin Zhou.   

Abstract

The low level of oxygenation within tumors is a major cause of radiation treatment failures. We theorized that anaerobic bacteria that can selectively destroy the hypoxic regions of tumors would enhance the effects of radiation. To test this hypothesis, we used spores of Clostridium novyi-NT to treat transplanted tumors in mice. The bacteria were found to markedly improve the efficacy of radiotherapy in several of the mouse models tested. Enhancement was noted with external beam radiation derived from a Cs-137 source, systemic radioimmunotherapy with an I-131-conjugated monoclonal antibody, and a previously undescribed form of experimental brachytherapy using plaques loaded with I-125 seeds. C. novyi-NT spores added little toxicity to the radiotherapeutic regimens, and the combination resulted in long-term remissions in a significant fraction of animals.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2003        PMID: 14657371      PMCID: PMC299912          DOI: 10.1073/pnas.2036598100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Can engineered bacteria help control cancer?

Authors:  R K Jain; N S Forbes
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 2.  Improving the efficacy of antibody-based cancer therapies.

Authors:  P Carter
Journal:  Nat Rev Cancer       Date:  2001-11       Impact factor: 60.716

3.  Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix.

Authors:  R Airley; J Loncaster; S Davidson; M Bromley; S Roberts; A Patterson; R Hunter; I Stratford; C West
Journal:  Clin Cancer Res       Date:  2001-04       Impact factor: 12.531

4.  Combination bacteriolytic therapy for the treatment of experimental tumors.

Authors:  L H Dang; C Bettegowda; D L Huso; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

Review 5.  External-beam radiotherapy in the management of liver metastases.

Authors:  Uzma Malik; Mohammed Mohiuddin
Journal:  Semin Oncol       Date:  2002-04       Impact factor: 4.929

Review 6.  Prospects for viral-based strategies enhancing the anti-tumor effects of ionizing radiation.

Authors:  S J Chmura; N Gupta; S J Advani; D W Kufe; R R Weichselbaum
Journal:  Semin Radiat Oncol       Date:  2001-10       Impact factor: 5.934

7.  Radioimmunotherapy of small-volume disease of metastatic colorectal cancer.

Authors:  Thomas M Behr; Torsten Liersch; Lutz Greiner-Bechert; Frank Griesinger; Martin Béhé; Peter M Markus; Stefan Gratz; Christa Angerstein; Gerhard Brittinger; Heinz Becker; David M Goldenberg; Wolfgang Becker
Journal:  Cancer       Date:  2002-02-15       Impact factor: 6.860

8.  Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix.

Authors:  M Hockel; K Schlenger; B Aral; M Mitze; U Schaffer; P Vaupel
Journal:  Cancer Res       Date:  1996-10-01       Impact factor: 12.701

9.  Limitations of conventional doses of chemoradiation for unresectable biliary cancer.

Authors:  Christopher H Crane; Kenneth O Macdonald; J N Vauthey; Patt Yehuda; Thomas Brown; Steven Curley; Adrian Wong; Marc Delclos; Chusilp Charnsangavej; Nora A Janjan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-07-15       Impact factor: 7.038

Review 10.  Impact of tumor hypoxia and anemia on radiation therapy outcomes.

Authors:  Louis B Harrison; Manjeet Chadha; Richard J Hill; Kenneth Hu; Daniel Shasha
Journal:  Oncologist       Date:  2002
View more
  42 in total

1.  Structural characterization of the polar lipids of Clostridium novyi NT. Further evidence for a novel anaerobic biosynthetic pathway to plasmalogens.

Authors:  Ziqiang Guan; Norah C Johnston; Semra Aygun-Sunar; Fevzi Daldal; Christian R H Raetz; Howard Goldfine
Journal:  Biochim Biophys Acta       Date:  2010-12-30

2.  Noninvasive imaging of infection after treatment with tumor-homing bacteria using Chemical Exchange Saturation Transfer (CEST) MRI.

Authors:  Guanshu Liu; Chetan Bettegowda; Yuan Qiao; Verena Staedtke; Kannie W Y Chan; Renyuan Bai; Yuguo Li; Gregory J Riggins; Kenneth W Kinzler; Jeff W M Bulte; Michael T McMahon; Assaf A Gilad; Bert Vogelstein; Shibin Zhou; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2013-10-07       Impact factor: 4.668

Review 3.  Tumour-targeting bacteria engineered to fight cancer.

Authors:  Shibin Zhou; Claudia Gravekamp; David Bermudes; Ke Liu
Journal:  Nat Rev Cancer       Date:  2018-12       Impact factor: 60.716

Review 4.  Salmonella-allies in the fight against cancer.

Authors:  Sara Leschner; Siegfried Weiss
Journal:  J Mol Med (Berl)       Date:  2010-06-05       Impact factor: 4.599

5.  Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses.

Authors:  Nicholas J Roberts; Linping Zhang; Filip Janku; Amanda Collins; Ren-Yuan Bai; Verena Staedtke; Saurabh Saha; Shibin Zhou; Anthony W Rusk; David Tung; Maria Miller; Jeffrey Roix; Kristen V Khanna; Ravi Murthy; Robert S Benjamin; Thorunn Helgason; Ariel D Szvalb; Justin E Bird; Sinchita Roy-Chowdhuri; Halle H Zhang; Yuan Qiao; Baktiar Karim; Jennifer McDaniel; Amanda Elpiner; Alexandra Sahora; Joshua Lachowicz; Brenda Phillips; Avenelle Turner; Mary K Klein; Gerald Post; Luis A Diaz; Gregory J Riggins; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Chetan Bettegowda; David L Huso; Mary Varterasian
Journal:  Sci Transl Med       Date:  2014-08-13       Impact factor: 17.956

Review 6.  The potential roles of bacteria to improve radiation treatment outcome.

Authors:  E Kouhsari; A Ghadimi-Daresajini; H Abdollahi; N Amirmozafari; S R Mahdavi; S Abbasian; S H Mousavi; H F Yaseri; M Moghaderi
Journal:  Clin Transl Oncol       Date:  2017-06-16       Impact factor: 3.405

7.  Optimized clostridium-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA cross-linking agent PR-104.

Authors:  Shie-Chau Liu; G-One Ahn; Mitomu Kioi; Mary-Jo Dorie; Adam V Patterson; J Martin Brown
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

Review 8.  Bacteria in cancer therapy: a novel experimental strategy.

Authors:  S Patyar; R Joshi; D S Prasad Byrav; A Prakash; B Medhi; B K Das
Journal:  J Biomed Sci       Date:  2010-03-23       Impact factor: 8.410

9.  Whole-Exome Sequencing of Salivary Gland Mucoepidermoid Carcinoma.

Authors:  Hyunseok Kang; Marietta Tan; Justin A Bishop; Siân Jones; Mark Sausen; Patrick K Ha; Nishant Agrawal
Journal:  Clin Cancer Res       Date:  2016-06-23       Impact factor: 12.531

Review 10.  Bacterial therapies: completing the cancer treatment toolbox.

Authors:  Adam T St Jean; Miaomin Zhang; Neil S Forbes
Journal:  Curr Opin Biotechnol       Date:  2008-09-18       Impact factor: 9.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.